Ben Goldacre
The Guardian,
Saturday October 25 2008
Welcome to nerds’ corner, and yet another small print criticism of a trivial act of borderline dubiousness which will ultimately lead to distorted evidence, irrational decisions, and bad outcomes in what I like to call “the real world”.
So the ClinPsyc blog (clinpsyc.blogspot.com ) has spotted that the drug company Lilly have published identical data on duloxetine – a new-ish antidepressant drug – twice over, in two entirely separate scientific papers. Read the rest of this entry »